Rosalba Mansi

2.6k total citations
59 papers, 2.1k citations indexed

About

Rosalba Mansi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology. According to data from OpenAlex, Rosalba Mansi has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Radiology, Nuclear Medicine and Imaging, 38 papers in Oncology and 34 papers in Epidemiology. Recurrent topics in Rosalba Mansi's work include Radiopharmaceutical Chemistry and Applications (39 papers), Neuroendocrine Tumor Research Advances (33 papers) and Lung Cancer Research Studies (21 papers). Rosalba Mansi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (39 papers), Neuroendocrine Tumor Research Advances (33 papers) and Lung Cancer Research Studies (21 papers). Rosalba Mansi collaborates with scholars based in Switzerland, Germany and Italy. Rosalba Mansi's co-authors include Jean Claude Reubi, Helmut R. Maëcke, Melpomeni Fani, Beatrice Waser, Renzo Cescato, Helmut R. Mäcke, Wolfgang Weber, Flavio Forrer, Maria‐Luisa Tamma and Damian Wild and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Rosalba Mansi

56 papers receiving 2.1k citations

Peers

Countries citing papers authored by Rosalba Mansi

Since Specialization

Citations

This map shows the geographic impact of Rosalba Mansi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalba Mansi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalba Mansi more than expected).

Fields of papers citing papers by Rosalba Mansi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalba Mansi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalba Mansi. The network helps show where Rosalba Mansi may publish in the future.

Co-authorship network of co-authors of Rosalba Mansi

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalba Mansi. A scholar is included among the top collaborators of Rosalba Mansi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalba Mansi. Rosalba Mansi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4 2025 ·ChemMedChem ·Raghuvir H. Gaonkar, Thèodorine Bailly, Jacopo Millul, Rosalba Mansi, Mirja Harms, Jan Münch, Melpomeni Fani	1
2	Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy 2024 ·Journal of Peptide Science ·Luigi Aloj, Rosalba Mansi, Stefania De Luca, Antonella Accardo, Diego Tesauro, Giancarlo Morelli	1
3	⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging 2024 ·Journal of Nuclear Medicine ·(unknown), Rosalba Mansi, Luigi Del Pozzo, (unknown), Raghuvir H. Gaonkar, Lisa McDougall, (unknown), (unknown), Michael Herz, Matthias Eiber, Gary A. Ulaner, Wolfgang Weber, Melpomeni Fani	8
4	CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors 2023 ·Journal of Translational Medicine ·(unknown), Rosalba Mansi, Raghuvir H. Gaonkar, (unknown), Melpomeni Fani, Philippe J. Eugster, Maja Beck‐Popovic, Eric Grouzmann, Karim Abid	3
5	Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists 2023 ·Pharmaceuticals ·Berthold A. Nock, (unknown), Lieke Joosten, Rosalba Mansi, Θεοδοσία Μάινα	25
6	Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jacopo Millul, Lennart Koepke, (unknown), Konstantin M. J. Sparrer, Rosalba Mansi, Melpomeni Fani	48
7	Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside 2021 ·CHIMIA International Journal for Chemistry ·Rosalba Mansi, Melpomeni Fani	3
8	Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers 2016 ·Journal of Nuclear Medicine ·Svetlana N. Rylova, Beatrice Waser, Luigi Del Pozzo, (unknown), Rosalba Mansi, Philipp T. Meyer, Jean Claude Reubi, Helmut R. Maëcke	20
9	Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients 2016 ·European Journal of Pharmaceutical Sciences ·Θεοδοσία Μάινα, Mark Konijnenberg, Petra Kolenc Peitl, Piotr Garnuszek, Berthold A. Nock, Aikaterini Kaloudi, (unknown), Katja Zaletel, Helmut R. Maëcke, Rosalba Mansi, Paola Anna Erba, Elisabeth von Guggenberg, Alicja Hubalewska‐Dydejczyk, Renata Mikołajczak, Clemens Decristoforo	36
10	Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors 2014 ·EJNMMI Research ·Andreas Wicki, Damian Wild, (unknown), Rosalba Mansi, Annette Orleth, Jean–Claude Reubi, Christoph Rochlitz, Christoph Mamot, Helmut R. Mäcke, Gerhard Christofori	4
11	Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men 2014 ·Theranostics ·Gesche Wieser, Rosalba Mansi, Anca-Ligia Grosu, Wolfgang Schultze‐Seemann, Rebecca A. Dumont, Philipp T. Meyer, Helmut R. Maëcke, Jean Claude Reubi, Wolfgang Weber	123
12	N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of ⁶⁸Ga- and ⁶⁴Cu-Labeled Peptides for PET Imaging 2014 ·Journal of Nuclear Medicine ·Eleni Gourni, Rosalba Mansi, (unknown), Beatrice Waser, Christiane Smerling, (unknown), Franz Buchegger, Jean Claude Reubi, Helmut R. Maëcke	50
13	Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties 2013 ·EJNMMI Research ·Susanne Kossatz, Rosalba Mansi, Martin Béhé, Peter Czerney, Ingrid Hilger	5
14	Targeting GRPR in urological cancers—from basic research to clinical application 2013 ·Nature Reviews Urology ·Rosalba Mansi, Achim Fleischmann, Helmut R. Mäcke, Jean Claude Reubi	100
15	Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens 2012 ·Molecular BioSystems ·Stefania Galdiero, Mariateresa Vitiello, Emiliana Finamore, Rosalba Mansi, Massimiliano Galdiero, Giancarlo Morelli, Diego Tesauro	2
16	Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells 2012 ·Journal of drug targeting ·Antonella Accardo, Rosalba Mansi, Giuseppina Salzano, (unknown), Michela Aurilio, Antonio Parisi, Francesco Μaione, Carla Cicala, (unknown), Diego Tesauro, Luigi Aloj, Giuseppe De Rosa, Giancarlo Morelli	35
17	Peptide modified nanocarriers for selective targeting of bombesin receptors 2010 ·Molecular BioSystems ·Antonella Accardo, Rosalba Mansi, (unknown), Gaetano Mangiapia, Luigi Paduano, Diego Tesauro, Aurel Rădulescu, Michela Aurilio, Luigi Aloj, Claudio Arra, Giancarlo Morelli	40
18	Tetraamine‐Derived Bifunctional Chelators for Technetium‐99m Labelling: Synthesis, Bioconjugation and Evaluation as Targeted SPECT Imaging Probes for GRP‐Receptor‐Positive Tumours 2010 ·Chemistry - A European Journal ·K. Abiraj, Rosalba Mansi, Maria‐Luisa Tamma, Flavio Forrer, Renzo Cescato, Jean Claude Reubi, (unknown), Helmut R. Maëcke	32
19	Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid–Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides 2009 ·Clinical Cancer Research ·Rosalba Mansi, Xuejuan Wang, Flavio Forrer, Stefan Kneifel, Maria‐Luisa Tamma, Beatrice Waser, Renzo Cescato, Jean Claude Reubi, Helmut R. Maëcke	147
20	In Vitro and In Vivo Characterization of Indium-111 and Technetium-99m Labeled CCK-8 Derivatives for CCK-B Receptor Imaging 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Luigi Aloj, Mariarosaria Panico, Corrado Caracò, Silvana Del Vecchio, Claudio Arra, Andrea Affuso, Antonella Accardo, Rosalba Mansi, Diego Tesauro, Stefania De Luca, Carlo Pedone, (unknown), Ulderico Mazzi, Giancarlo Morelli, Marco Salvatore	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact